The underlying cause of cervical cancer in oral contraceptive users may be related to cervical mucus changes

被引:4
作者
Guven, Suleyman
Kart, Cavit
Seda, Emine
Guven, Guvendag
Gunalp, G. Serdar
机构
[1] Karadeniz Tech Univ, Sch Med, Dept Obstet & Gynecol, Trabzon, Turkey
[2] Hacettepe Univ, Sch Med, Dept Obstet & Gynecol, Ankara, Turkey
[3] Etlik Womens hlth & Matern Teaching Hosp, Dept Obstet & Gynecol, Ankara, Turkey
关键词
D O I
10.1016/j.mehy.2007.01.051
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Oral contraceptives (OCs) remain among the most effective reversible methods of birth control available today, providing almost 100% effectiveness with an impressively high margin of safety and other important health benefits. However, concerns have been raised about the role that the hormones in OCs might play in the pathogenesis of cervical cancer. Evidence shows that long-term use of OCs (five or more years) may be associated with an increased risk of cancer of the cervix. The mechanism of increased risk of cervical cancer in OCs users has long been debated, and remains uncertain. Our hypothesis is that scanty, thick, and highly viscous cervical mucus obtained in OCs users intimately involved in the pathogenesis of cervical cancer. Possibly, this architecture of cervical mucus may modulate and prolong the effect of carcinogenic agents, which have been carried by coitus and stored in posterior vaginal fornix, on squamocolumnar junction of cervix by not permitting them to be removed because of its highly viscous pattern. The rote of cervical mucus changes by means of specific mucin protein changes on the pathophysiology of cervical cancer in OCs users should be investigated. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:550 / 552
页数:3
相关论文
共 15 条
[1]  
Baker AC, 2006, ARCH PATHOL LAB MED, V130, P1510
[2]   Safety concerns and health benefits associated with oral contraception [J].
Burkman, R ;
Schlesselman, JJ ;
Zieman, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (04) :S5-S22
[3]  
Franceschi S, 2005, RECENT RESULTS CANC, V166, P277
[4]   MUC4 and MUC5B transcripts are the prevalent mucin messenger ribonucleic acids of the human endocervix [J].
Gipson, IK ;
Spurr-Michaud, S ;
Moccia, R ;
Zhan, Q ;
Toribara, N ;
Ho, SB ;
Gargiulo, AR ;
Hill, JA .
BIOLOGY OF REPRODUCTION, 1999, 60 (01) :58-64
[5]   Mucins of the human endocervix [J].
Gipson, IK .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2001, 6 :D1245-D1255
[6]   The amount of MUC5B mucin in cervical mucus peaks at midcycle [J].
Gipson, IK ;
Moccia, R ;
Spurr-Michaud, S ;
Argüeso, P ;
Gargiulo, AR ;
Hill, JA ;
Offner, GD ;
Keutmann, HT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :594-600
[7]  
Hedon B, 1990, Acta Obstet Gynecol Scand Suppl, V152, P7
[8]   Developments in contraception:: A comprehensive review of desogen® (Desogestrel and ethinyl estradiol) [J].
Lammers, P ;
Blumenthal, PD ;
Huggins, GR .
CONTRACEPTION, 1998, 57 (05) :1S-27S
[9]   The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: A review [J].
Moodley, M ;
Moodley, J ;
Chetty, R ;
Herrington, CS .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (02) :103-110
[10]   HUMAN CERVICAL-MUCUS - RELATIONSHIP BETWEEN BIOCHEMICAL CHARACTERISTICS AND ABILITY TO ALLOW MIGRATION OF SPERMATOZOA [J].
MORALES, P ;
ROCO, M ;
VIGIL, P .
HUMAN REPRODUCTION, 1993, 8 (01) :78-83